Fibrinogen: Its Emerging Role as a Cardiovascular Risk Factor
- 1 February 1994
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 45 (2) , 87-93
- https://doi.org/10.1177/000331979404500201
Abstract
Several epidemiologic studies have produced longitudinal data identifying fibrinogen as a major cardiovascular risk factor. Cross-sectional results show strong associations between fibrinogen and cardiovascular risk factors or dis eases. Clinical cohort studies demonstrate that fibrinogen might also be a risk factor for the sequelae of cardiovascular disease. At present, knowledge about the determinants of the plasma level of fibrinogen in health and disease is in complete. Understanding of the mechanisms that might be involved in the atherogenic action of fibrinogen is also fragmentary. Fibrinogen strongly affects blood coagulation, blood rheology, and platelet aggregation, and in addition it has direct effects on the vascular wall and is a prominent acute-phase reactant. All of these phenomena might provide some insight into the pathophysiologic mechanisms involved in the association between fibrinogen and cardiovascular events. Even though many crucial questions await answers, it is concluded that fibrinogen represents a major, independent risk factor that should be consid ered for screening programs aimed at identifying individuals at high risk for cardiovascular disease.Keywords
This publication has 43 references indexed in Scilit:
- Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.Circulation, 1991
- Plasma fibrinogen and ischemic heart disease risk factors.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Plasma fibrinogen and coronary risk factors: The Scottish heart health studyJournal of Clinical Epidemiology, 1990
- The Normal and Morbid Biology of FibrinogenThe American Journal of Medicine, 1989
- Fibrinogen and Risk of Cardiovascular DiseaseJAMA, 1987
- COAGULATION FACTORS AND THE PROGRESS OF CORONARY HEART DISEASEThe Lancet, 1987
- Fibrinogen, cigarette smoking, and risk of cardiovascular disease: Insights from the Framingham StudyAmerican Heart Journal, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980